Legal & General Group’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$14.8K Hold
2025
Q2
$17.2K Sell
2025
Q1
$180K Hold
2024
Q4
$344K Buy
2024
Q3
$251K Buy
2024
Q2
$212K Buy
2024
Q1
$157K Hold
2023
Q4
$167K Hold
2023
Q3
$175K Sell
2023
Q2
$171K Buy
2023
Q1
$51.8K Buy
2022
Q4
$39.7K Buy
2022
Q2
Sell
2022
Q1
$8K Hold
2021
Q4
$15K Buy